$ELVN 4 SEC Filings

Filed On	Filing
21 Oct 2026	Form 4: Hohl Benjamin, CHIEF FINANCIAL OFFICER Received 6,018 shares by exercise or conversion ($89.4K) · Sold 6,018 shares ($232K)
21 Oct 2026	Form 4: Collins Helen Louise, CHIEF MEDICAL OFFICER Received 5,000 shares by exercise or conversion ($12.4K) · Sold 5,000 shares ($192K)
16 Oct 2026	Form 4: Ball Kristine M, Director Granted 23,394 Stock Option (right to buy)
05 Oct 2026	Form 4: Garland J. Scott, Director Received 13,000 shares by exercise or conversion ($201K) · Sold 13,000 shares ($607K)
21 Sep 2026	Form 4: Hohl Benjamin, CHIEF FINANCIAL OFFICER Received 3,982 shares by exercise or conversion ($59.1K) · Sold 6,018 shares ($303K)
21 Sep 2026	Form 4: Collins Helen Louise, CHIEF MEDICAL OFFICER Received 5,000 shares by exercise or conversion ($12.4K) · Sold 5,000 shares ($252K)
19 Aug 2026	Form 4: Hohl Benjamin, CHIEF FINANCIAL OFFICER Sold 6,018 shares ($353K)
19 Aug 2026	Form 4: Collins Helen Louise, CHIEF MEDICAL OFFICER Received 5,000 shares by exercise or conversion ($12.4K) · Sold 5,000 shares ($293K)
06 Aug 2026	Form 4: Derynck Mika K, Director Received 158,795 shares by exercise or conversion ($1.72M) · Sold 158,795 shares ($9.56M)
21 Jul 2026	Form 4: Hohl Benjamin, CHIEF FINANCIAL OFFICER Received 1,072 shares by exercise or conversion ($2.66K) · Sold 6,018 shares ($317K)
21 Jul 2026	Form 4: Collins Helen Louise, CHIEF MEDICAL OFFICER Received 5,000 shares by exercise or conversion ($12.4K) · Sold 5,000 shares ($263K)
08 Jul 2026	Form 4: Kunkel Lori Anne, Director Sold 10,000 shares ($505K)
24 Jun 2026	Form 4: Orbimed Advisors Llc, 10% owner and 2 others Sold 860,123 shares ($39M)
22 Jun 2026	Form 4: Hohl Benjamin, CHIEF FINANCIAL OFFICER Received 6,018 shares by exercise or conversion ($14.9K) · Sold 6,018 shares ($264K)
22 Jun 2026	Form 4: Collins Helen Louise, CHIEF MEDICAL OFFICER Received 5,000 shares by exercise or conversion ($12.4K) · Sold 5,000 shares ($219K)
17 Jun 2026	Form 4: Orbimed Advisors Llc, 10% owner and 2 others Sold 281,408 shares ($12.7M)
09 Jun 2026	Form 4: Kunkel Lori Anne, Director Sold 10,000 shares ($345K)
20 May 2026	Form 4: Collins Helen Louise, CHIEF MEDICAL OFFICER Received 5,000 shares by exercise or conversion ($12.4K) · Sold 5,000 shares ($199K)
21 Apr 2026	Form 4: Collins Helen Louise, CHIEF MEDICAL OFFICER Received 5,000 shares by exercise or conversion ($12.4K) · Sold 5,000 shares ($238K)
27 Mar 2026	Form 4: Collins Helen Louise, CHIEF MEDICAL OFFICER Received 40,000 shares by exercise or conversion ($99.2K) · Sold 40,000 shares ($1.4M)

Comments